Prognostic value of N-terminal Pro-B-Type natriuretic peptide in patients with intermediate coronary lesions.

ABSTRACT:

Background

The optimal treatment strategy for patients with coronary intermediate lesions, defined as diameter stenosis of 50-70%, remains a great challenge for cardiologists. Identification of potential biomarkers predictive of major adverse cardiovascular events (MACEs) risk may assist in risk stratification and clinical decision.

Methods

A total of 1,187 patients with intermediate coronary lesions and available N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were enrolled in the current study. A baseline NT-proBNP level was obtained. The primary endpoint was defined as MACEs, the composite endpoint of all-cause death and non-fatal myocardial infarction. A multivariate Cox regression model was used to explore the association between NT-proBNP level and MACE ris

SUBMITTER: Song C 

PROVIDER: S-EPMC9370998 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature